Skip to content

Feed Screener Search Methodology

SEC · FI · BAFIN · AFM · AMF

Pricing Sign in

InsiderLens

Statistics predict. AI explains.

Insider transactions from public regulatory disclosures, aggregated and enriched with deterministic statistical signals. Not investment advice.

Sources

SEC EDGAR · US
FINANSINSPEKTIONEN · SE
BAFIN · DE
AFM · NL
AMF · FR

Product

Methodology
Privacy notice
Object to processing

Feed Screener Search Methodology

Pricing Sign in

QLT INC/BC — Aralez Pharmaceuticals Inc. insider: 1 transactions · InsiderLens

Home / Insiders / QLT INC/BC

QLT INC/BC

10% owner at Aralez Pharmaceuticals Inc. · on record since Feb 5, 2016
10% owner at Aegerion Pharmaceuticals, Inc. · on record since Jun 23, 2016

Insider trading activity of QLT INC/BC

Transactions on record: 1; since Apr 7, 2016

Open-market buys: 0

Open-market sells: 1; $15M

Companies traded: 1; last filing Apr 7, 2016

Figures computed from official regulatory filings — methodology.

Companies where QLT INC/BC has traded

Aralez Pharmaceuticals Inc.1 tx · $15M · Apr 7, 2016

Track record of QLT INC/BC

Insufficient history for a statistical track record (fewer than 5 open-market buys).

Transaction history of QLT INC/BC

Co-insiders of QLT INC/BC

ADAMS ADRIANAralez Pharmaceuticals Inc.
Advent Healthcare & Life Sciences III-A Limited PartnershipAegerion Pharmaceuticals, Inc.
ADVENT HEALTHCARE & LIFE SCIENCES III LIMITED PARTNERSHIPAegerion Pharmaceuticals, Inc.
ADVENT INTERNATIONAL CORP/MAAegerion Pharmaceuticals, Inc.
ADVENT INTERNATIONAL LLCAegerion Pharmaceuticals, Inc.
Advent Partners HLS III Limited PartnershipAegerion Pharmaceuticals, Inc.
AHLS III GP LIMITED PARTNERSHIP

This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →

Aegerion Pharmaceuticals, Inc.

ALTA BIOPHARMA MANAGEMENT III LLCAegerion Pharmaceuticals, Inc.

ALTA BIOPHARMA PARTNERS III GMBH & CO BETEILIGUNGS KGAegerion Pharmaceuticals, Inc.

ALTA BIOPHARMA PARTNERS III LPAegerion Pharmaceuticals, Inc.

ALTA EMBARCADERO BIOPHARMA PARTNERS III LLCAegerion Pharmaceuticals, Inc.

Andrews William T.Aegerion Pharmaceuticals, Inc.

Armstrong Jennifer LouAralez Pharmaceuticals Inc.

Aryeh JasonAralez Pharmaceuticals Inc.

Aubuchon DavidAegerion Pharmaceuticals, Inc.

BARER SOL JAegerion Pharmaceuticals, Inc.

BARNHARDT JOHN EAralez Pharmaceuticals Inc.

Beer Marc DAegerion Pharmaceuticals, Inc.

Broadfin Capital, LLCAegerion Pharmaceuticals, Inc.

Broadfin Healthcare Master Fund LtdAegerion Pharmaceuticals, Inc.

Buono LindaAegerion Pharmaceuticals, Inc.

CARTER MARTHA JAegerion Pharmaceuticals, Inc.

Cavan John TAegerion Pharmaceuticals, Inc.

CHAMPSI FARAHAegerion Pharmaceuticals, Inc.

Chan Barbara YAegerion Pharmaceuticals, Inc.

Charles Scott JAralez Pharmaceuticals Inc.

Cook Anne MarieAegerion Pharmaceuticals, Inc.

Curtis EricAegerion Pharmaceuticals, Inc.

DELEAGE JEANAegerion Pharmaceuticals, Inc.

EDELMAN JOSEPHAegerion Pharmaceuticals, Inc.

FISHERMAN JASON SAegerion Pharmaceuticals, Inc.

Fitzpatrick Mark J.Aegerion Pharmaceuticals, Inc.

Fowler Neal FranklinAralez Pharmaceuticals Inc.

Fraser CraigAegerion Pharmaceuticals, Inc.

Glickman Mark AAralez Pharmaceuticals Inc.

GOTTO ANTONIO M JR MD D PHILAegerion Pharmaceuticals, Inc.

Harris Robert PaulAralez Pharmaceuticals Inc.

Harshbarger BenjaminAegerion Pharmaceuticals, Inc.

HURWITZ EDWARDAegerion Pharmaceuticals, Inc.

Index Venture Associates III LtdAegerion Pharmaceuticals, Inc.

Index Ventures III (Delaware) L.P.Aegerion Pharmaceuticals, Inc.

Index Ventures III (Jersey) L.P.Aegerion Pharmaceuticals, Inc.

Index Ventures III Parallel Entrepreneur Fund (Jersey) L.P.Aegerion Pharmaceuticals, Inc.

Kaseta MichaelAralez Pharmaceuticals Inc.

Kirsch Arthur SAralez Pharmaceuticals Inc.

KOTLER KEVINAegerion Pharmaceuticals, Inc.

KOVEN ANDREW IAralez Pharmaceuticals Inc.

LEE KENNETH B JRAralez Pharmaceuticals Inc.

Lewis WilliamAegerion Pharmaceuticals, Inc.

Louis RogerAegerion Pharmaceuticals, Inc.

Company	Filed	Type	Qty	Price	Value · USD	Src
Aralez Pharmaceuticals Inc.	Apr 7, 2016	Sell	-2,400,000	6.25 USD	$15M	SEC